Stay updated on Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest updates to the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check32 days agoNo Change Detected
- Check47 days agoChange DetectedThe study has expanded to include 13 locations, and the website has been updated to Revision v2.10.0, replacing the previous Revision v2.9.7.SummaryDifference0.5%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check60 days agoChange DetectedDifference0.3%
- Check64 days agoChange DetectedDifference0.3%
Stay in the know with updates to Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.